Haguenoer, K
Sengchanh, S
Gaudy-Graffin, C
Boyard, J
Fontenay, R
Marret, H
Goudeau, A
Pigneaux de Laroche, N
Rusch, E
Giraudeau, B
Article History
Received: 2 June 2014
Revised: 8 August 2014
Accepted: 20 August 2014
First Online: 23 September 2014
Competing interests
: Dr Haguenoer received grant support from the French National Cancer Institute and French League Against Cancer; received support from Innogenetics and Sanofi Pasteur MSD for travel expenses to an HPV congress; and participated without compensation in meetings on cervical cancer prevention organised by Sanofi Pasteur MSD and GlaxoSmithKline. Dr Sengchanh and Dr Gaudy-Graffin received support from Innogenetics and Sanofi Pasteur MSD for travel expenses to an HPV congress and participated without compensation in meetings on cervical cancer prevention organised by Sanofi Pasteur MSD and GlaxoSmithKline. Dr Marret was invited to an international congress on HPV and participated without compensation in meetings on cervical cancer prevention organised by Sanofi Pasteur MSD and GlaxoSmithKline. The remaining co-authors report no financial disclosures. We did not use any writing assistance but used English language editing services.